MarketCap
Facebook
X
Telegram
Intuitive Surgical Book Value | ISRG
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Intuitive Surgical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.9 B | 16.5 B | 13.4 B | 11.1 B | 12 B | 9.76 B | 8.28 B | 6.69 B | 4.73 B | 5.78 B | 4.32 B | 3.38 B | 3.5 B | 3.58 B | 2.65 B | 2.04 B | 1.54 B | 1.27 B | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.9 B | 1.27 B | 7.14 B |
Quarterly Book Value Intuitive Surgical
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | 2009-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.3 B | 17.6 B | 17.9 B | 17 B | 18 B | 17.2 B | 16.5 B | 15.7 B | 14.8 B | 14 B | 13.4 B | 12.6 B | - | 11.3 B | 11.1 B | 11.6 B | - | 12.2 B | 12 B | 11.5 B | 10.9 B | 10.2 B | 9.76 B | 9.76 B | 9.76 B | 9.76 B | 8.28 B | 8.28 B | 8.28 B | 8.28 B | 6.69 B | 6.69 B | 6.69 B | 6.69 B | 4.78 B | 4.78 B | 4.78 B | 4.78 B | 5.78 B | 5.78 B | 5.78 B | 5.78 B | 4.32 B | 4.32 B | 4.32 B | 4.32 B | 3.38 B | 3.38 B | 3.38 B | 3.38 B | 3.5 B | 3.5 B | 3.5 B | 3.5 B | 3.58 B | 3.58 B | 3.58 B | 3.58 B | 2.65 B | 2.65 B | 2.65 B | 2.65 B | 2.01 B | 1.92 B | 1.77 B | 1.39 B | 1.27 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.3 B | 1.27 B | 7.74 B |
Book Value of other stocks in the Medical instruments industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AtriCure
ATRC
|
492 M | $ 35.04 | 6.18 % | $ 1.67 B |  USA |
 |
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
199 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
76.5 M | - | -9.52 % | $ 20.6 M | USA |
 |
BioLife Solutions
BLFS
|
372 M | $ 29.98 | -2.57 % | $ 1.43 B | USA |
 |
CRH Medical Corporation
CRHM
|
762 M | - | - | $ 282 M | USA |
 |
ResMed
RMD
|
5.97 B | $ 195.27 | 1.76 % | $ 28.6 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
257 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
411 M | - | -1.18 % | $ 3.4 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
388 M | - | -0.05 % | $ 10.3 B | USA |
 |
STAAR Surgical Company
STAA
|
344 M | $ 23.38 | -3.35 % | $ 1.16 B | USA |
 |
STERIS plc
STE
|
7.2 B | $ 214.07 | 1.64 % | $ 21 B | USA |
 |
Teleflex Incorporated
TFX
|
3.12 B | $ 132.1 | 0.69 % | $ 5.89 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
9.03 M | - | - | $ 28.6 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
66.7 M | - | -0.02 % | $ 16.3 B | USA |
 |
Nephros
NEPH
|
10.2 M | $ 3.64 | -3.45 % | $ 38.6 M | USA |
 |
West Pharmaceutical Services
WST
|
3.18 B | $ 328.2 | -7.67 % | $ 23.7 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.34 B | $ 12.93 | 1.65 % | $ 2.58 B | USA |
 |
Isoray
ISR
|
207 M | - | 0.03 % | $ 108 M | USA |
 |
electroCore
ECOR
|
-1.71 M | $ 6.19 | -2.75 % | $ 52.5 K | USA |
 |
Haemonetics Corporation
HAE
|
2.4 B | $ 78.78 | 1.78 % | $ 3.72 B | USA |
 |
Predictive Oncology
POAI
|
47.7 M | - | - | $ 31.1 M | USA |
 |
The Cooper Companies
COO
|
8.24 B | $ 70.31 | 0.11 % | $ 14 B | USA |
 |
AngioDynamics
ANGO
|
171 M | $ 13.59 | 1.12 % | $ 564 M | USA |
 |
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
Pulse Biosciences
PLSE
|
80.7 M | $ 30.23 | -2.48 % | $ 2.04 B | USA |
 |
iRhythm Technologies
IRTC
|
153 M | $ 109.2 | 1.42 % | $ 3.49 B | USA |
 |
Repligen Corporation
RGEN
|
2.11 B | $ 131.96 | -4.1 % | $ 7.42 M | USA |
 |
Pro-Dex
PDEX
|
36.6 M | $ 54.93 | 0.48 % | $ 181 M | USA |
 |
Merit Medical Systems
MMSI
|
1.58 B | $ 74.32 | 1.66 % | $ 4.4 B | USA |
 |
InfuSystem Holdings
INFU
|
57.3 M | $ 9.12 | 2.59 % | $ 188 M | USA |
 |
Glaukos Corporation
GKOS
|
656 M | $ 153.58 | 0.95 % | $ 8.78 B | USA |
 |
Baxter International
BAX
|
6.1 B | $ 22.4 | 3.37 % | $ 11.5 B | USA |
 |
Harvard Bioscience
HBIO
|
13.7 M | $ 6.0 | -3.56 % | $ 266 M | USA |
 |
ICU Medical
ICUI
|
4.05 B | $ 157.44 | 2.59 % | $ 3.88 B | USA |
 |
Alcon
ALC
|
22 B | $ 67.91 | 1.04 % | $ 40.4 B |  Schweiz |
 |
Stereotaxis
STXS
|
18.7 M | $ 1.29 | -8.51 % | $ 117 M | USA |
 |
Milestone Scientific
MLSS
|
2.81 M | $ 0.39 | -2.94 % | $ 32 M | USA |
 |
Envista Holdings Corporation
NVST
|
5.68 B | $ 26.33 | 0.61 % | $ 4.42 B | USA |
 |
Masimo Corporation
MASI
|
1.05 B | - | - | $ 9.59 B | USA |
 |
Microbot Medical
MBOT
|
77.6 M | $ 1.71 | -2.84 % | $ 78.3 M |  Israel |
 |
Repro Med Systems
KRMD
|
17 M | $ 3.83 | 2.68 % | $ 177 M | USA |
 |
OraSure Technologies
OSUR
|
341 M | $ 3.97 | -1.49 % | $ 292 M | USA |
 |
LeMaitre Vascular
LMAT
|
394 M | $ 95.59 | -1.95 % | $ 2.16 B | USA |
 |
Becton, Dickinson and Company
BDX
|
55.3 B | $ 156.36 | 2.22 % | $ 45 B | USA |
 |
Retractable Technologies
RVP
|
74.4 M | $ 0.68 | - | $ 20.4 M | USA |
 |
Utah Medical Products
UTMD
|
119 M | $ 67.14 | 4.61 % | $ 218 M | USA |